KD Logo

Wells Fargo Upgrades Globus Medical Inc (GMED) to an Overweight from an Equal weight

Globus Medical Inc’s recently made public that its Director Davidar David D unloaded Company’s shares for reported $1.13 million on Nov 21 ’24. In the deal valued at $85.00 per share,13,254 shares were sold. As a result of this transaction, Davidar David D now holds 172,713 shares worth roughly $14.59 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Davidar David D sold 13,234 shares, generating $1,124,890 in total proceeds. Upon selling the shares at $85.00, the Director now owns 523,041 shares.

Before that, Davidar David D sold 6,766 shares. Globus Medical Inc shares valued at $575,135 were divested by the Director at a price of $85.00 per share. As a result of the transaction, Davidar David D now holds 516,275 shares, worth roughly $43.62 million.

Wells Fargo upgraded its Globus Medical Inc [GMED] rating to an Overweight from a an Equal weight in a research note published on August 07, 2024; the price target was increased to $78 from $60. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid May from “a Neutral” to “an Overweight”. BTIG Research also remained covering GMED and has increased its forecast on March 18, 2024 with a “Buy” recommendation from previously “Neutral” rating. ROTH MKM started covering the stock on October 20, 2023. It rated GMED as “a Buy”.

Price Performance Review of GMED

On Monday, Globus Medical Inc [NYSE:GMED] saw its stock fall -0.27% to $84.49. Over the last five days, the stock has gained 3.25%. Globus Medical Inc shares have risen nearly 58.55% since the year began. Nevertheless, the stocks have risen 82.41% over the past one year. While a 52-week high of $85.30 was reached on 11/25/24, a 52-week low of $44.02 was recorded on 05/01/24. SMA at 50 days reached $75.05, while 200 days put it at $65.50.

Levels Of Support And Resistance For GMED Stock

The 24-hour chart illustrates a support level at 83.95, which if violated will result in even more drops to 83.41. On the upside, there is a resistance level at 85.18. A further resistance level may holdings at 85.87. The Relative Strength Index (RSI) on the 14-day chart is 70.49, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.95, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.89%. Stochastics %K at 92.98% indicates the stock is a selling.

How much short interest is there in Globus Medical Inc?

A steep rise in short interest was recorded in Globus Medical Inc stocks on 2024-10-31, dropping by -0.56 million shares to a total of 2.86 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.41 million shares. There was a decline of -19.56%, which implies that there is a negative sentiment for the stock.

Most Popular